Home Tags Pharmaceutical Industry

Tag: Pharmaceutical Industry

Joe Papa, CEO of Valeant

Embattled pharma company Valeant is changing its name as it seeks to revamp image

Embattled pharma company Valeant Pharmaceuticals is changing its name to Bausch Health Companies. The former stock market darling has had a rough couple of years after its pricing practices came under scrutiny in 2015. The name-change goes into effect in July.
Former Rockford Mayor Larry Morrissey

How a city in Illinois decided to sue to combat high drug prices after realizing it was spending $500,000 on one drug

A recent "60 Minutes" episode highlighted a lawsuit between Rockford Illinois, and a drugmaker over the rising cost of prescription drugs that led to the city spending half a million dollars treating two babies.

A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift

Johnson & Johnson plans to file for FDA approval of a nasal formula of ketamine for depression this year. A new study presented on Saturday suggest the drug, called esketamine, is linked with some very positive results, especially in people with the hardest to treat forms of depression.
Allergan CEO Brent Saunders

Investors are frustrated with Botox-maker Allergan — and its CEO says it’s ‘deep into the process’ of figuring out what to do ...

Allergan said Monday during its first-quarter earnings call that it's "deep into the process" of its strategic review of the company amid its stock price slipping over the past year.

A biotech company’s farthest-along drug just failed a key trial — and the stock is plummeting

Prothena said on Monday that its drug to treat AL Amyloidosis failed a key trial, leading the company to discontinue a later-stage study.

There could be a $35 billion market to treat NASH, a ‘silent disease’ millions are living with — and the competition’s startin...

Work's being done to pinpoint how to treat NASH, as well as research that's being used to better understand the genetics of the disease.

We’re about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated

On Monday, three big players in the growing field of cancer immunotherapy are sharing data that could change how we treat lung cancer.

‘There’s other s— in the vial’: Bombshell lawsuit claims no one knows exactly what’s in a drug that’s cost the gov...

OPINION: The government has spent over a billion on a drug called Acthar and allegedly no one at the company even knows what it's actually made of.
Novartis CEO Vas Narasimhan

Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases

Novartis is acquiring gene therapy company AveXis for $8.7 billion. It's part of a wave of big bets in gene therapy, a cutting-edge area of science that has had some big advancements over the past year.
TwoXar cofounders Andrew M. Radin and Andrew A. Radin

A startup that uses software to discover new drugs just raised $10 million

TwoXar, a startup that uses software to discover new, experimental drugs, just raised $10 million from investors including SoftBank Ventures.